Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
FOS | JUNB | JUNB: Transcription factor jun-B | 5.36E3 | Evidence | O | ||||
FOS | JUN | JUN: Transcription factor AP-1 | 2.51E3 | Evidence | O | ||||
FOS | MAFB | MAFB, KRML: Transcription factor MafB | 201.0 | Evidence | |||||
FOS | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 114.0 | Evidence | |||||
FOS | ETS2 | ETS2: Protein C-ets-2 | 70.20 | Evidence | |||||
FOS | FOSL2 | FOSL2, FRA2: Fos-related antigen 2 | 62.90 | Evidence | |||||
FOS | RXRA | RXRA, NR2B1: Retinoic acid receptor RXR-alpha | 59.5 | Evidence | |||||
FOS | ATF1 | ATF1: Cyclic AMP-dependent transcription factor ATF-1 | 51.50 | Evidence | |||||
FOS | CREBBP | CREBBP, CBP: CREB-binding protein | 51.50 | Evidence | |||||
FOS | BATF | BATF: Basic leucine zipper transcriptional factor ATF-like | 43.60 | Evidence | O | ||||
FOS | RB1 | RB1: Retinoblastoma-associated protein | 43.60 | Evidence | O | ||||
FOS | NFE2L2 | NFE2L2, NRF2: Nuclear factor erythroid 2-related factor 2 | 39.10 | Evidence | |||||
FOS | MAPK9 | MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 | 37.80 | Evidence | |||||
FOS | NR3C1 | NR3C1, GRL: Glucocorticoid receptor | 35.40 | Evidence | |||||
FOS | MYB | MYB: Myb proto-oncogene protein | 34.80 | Evidence | |||||
FOS | GTF2F2 | N/A | 34.80 | Evidence | O | ||||
FOS | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 32.90 | Evidence | |||||
FOS | VDR | VDR, NR1I1: Vitamin D3 receptor | 31.70 | Evidence | |||||
FOS | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 31.20 | Evidence | |||||
FOS | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 28.20 | Evidence | |||||
FOS | FOSB | FOSB, G0S3: Protein fosB | 28.2 | Evidence | |||||
FOS | MAP2K6 | MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki | 26.90 | Evidence | |||||
FOS | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 26.00 | Evidence | |||||
FOS | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 25.3 | Evidence | |||||
FOS | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 24.90 | Evidence | |||||
FOS | MAPK10 | MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 | 24.90 | Evidence | |||||
FOS | DDIT3 | DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 | 22.40 | Evidence | O | ||||
FOS | EGR1 | EGR1, ZNF225: Early growth response protein 1 | 19.90 | Evidence | |||||
FOS | SMAD4 | SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 | 19.70 | Evidence | |||||
FOS | SMAD3 | SMAD3, MADH3: Mothers against decapentaplegic homolog 3 | 19.70 | Evidence | |||||
FOS | GTF2B | GTF2B, TF2B, TFIIB: Transcription initiation factor IIB | 19.70 | Evidence | |||||
FOS | RELA | RELA, NFKB3: Transcription factor p65 | 19.70 | Evidence | |||||
FOS | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 19.70 | Evidence | |||||
FOS | TCF20 | TCF20, KIAA0292, SPBP: Transcription factor 20 | 19.10 | Evidence | |||||
FOS | ZNF295 | ZNF295, KIAA1227, ZBTB21: Zinc finger protein 295 | 19.10 | Evidence | |||||
FOS | DMXL2 | DMXL2, KIAA0856: DmX-like protein 2 | 17.80 | Evidence | |||||
FOS | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 17.10 | Evidence | |||||
FOS | SOX8 | SOX8: Transcription factor SOX-8 | 17.10 | Evidence | |||||
FOS | ATAD2 | ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 | 16.40 | Evidence | |||||
FOS | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 16.30 | Evidence | |||||
FOS | NFIL3 | NFIL3, E4BP4, IL3BP1: Nuclear factor interleukin-3-regulated protein | 15.30 | Evidence | |||||
FOS | HCK | N/A | 15.10 | Evidence | |||||
FOS | EP300 | N/A | 14.40 | Evidence | |||||
FOS | BARD1 | BARD1: BRCA1-associated RING domain protein 1 | 14.20 | Evidence | |||||
FOS | RIPK1 | RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 | 13.80 | Evidence | |||||
FOS | NR5A1 | NR5A1, AD4BP, FTZF1, SF1: Steroidogenic factor 1 | 12.70 | Evidence | |||||
FOS | STAT4 | STAT4: Signal transducer and activator of transcription 4 | 12.50 | Evidence | |||||
FOS | PGR | PGR, NR3C3: Progesterone receptor | 12.50 | Evidence | |||||
FOS | GRK1 | GRK1, RHOK: Rhodopsin kinase precursor | 12.50 | Evidence |